(Q37206159)

18 August 2017

1 reference

title

Recent advances in the molecular diagnosis and prognosis of colorectal cancer (English)

1 reference

18 August 2017

0 references

1 reference

Sergio Huerta

1

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

277-288

1 reference

A genetic model for colorectal tumorigenesis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

21 January 2018

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Detecting colorectal cancer in stool with the use of multiple genetic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Genetic profiling of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

The DCC protein and prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Colon cancer and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Control of apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Intratumoral molecular or genetic markers as predictors of clinical outcome with chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Systematic review of genetic influences on the prognosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low‐turnover tumors with distinct clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Clinical practice. Surveillance strategies after curative treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Molecular diagnosis of the hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Mesorectal excision for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

21 January 2018

The molecular outlook

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.277

21 January 2018

Identifiers

DOI

10.1586/14737159.8.3.277

1 reference

18 August 2017

1 reference